Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
Randomized Phase III Trial of Pembrolizumab vs. Pembrolizumab/Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Platinum Refractory Disease.
Study Type: Treatment
Phase: III
NCTID: NCT06589804
Principal Investigator:
Prakash Neupane
A Phase II Trial of sEphB4-HSA in Combination with Anti PD1 Antibody Pembrolizumab, MK-3475 for Solid Tumors
An Open-Label Randomized Phase II Trial of SAR439859, Versus Endocrine Monotherapy as Per Physician?s Choice in Patients with Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer with Prior Exposure to Hormonal Therapies AMEERA 3
Multi-Center Randomized Controlled Phase 2b Clinical Trial To Evaluate The Safety And Efficacy Of Tvi-Brain-1 Combined With Conformal Radiotherapy And Temozolomide Compared To Standard Therapy As A Treatment For Newly Diagnosed O6 -Methylguanine Methyltransferase Negative MGMT Unmethylated Grade 4 Astrocytoma Glioblastoma Multiforme; GBM
Study Type: Treatment
Phase: II
NCTID: NCT05685004
Principal Investigator:
Tolga Tuncer
A Phase IIB Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + Umbralisib with or without Bendamustine and Umbralisib alone in Patients with Previously Treated Non-Hodgkin?s Lymphoma
Study Type: Treatment
Phase: II
NCTID: NCT02793583
Principal Investigator:
Marc Hoffmann
SL-401 in Patients with Advanced, High-Risk Myeloproliferative Neoplasms MPN
Nodular Lymphocyte-predominant Hodgkin Lymphoma Patients Treated in a Randomized Phase II Trial with Either Rituximab or Mosunetuzumab NORM
Study Type: Treatment
Phase: II
NCTID: NCT05886036
Principal Investigator:
Marc Hoffmann
GRAVITAS-309: A Phase II/III Study of Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
A Phase II Trial of Perioperative CV301 Vaccination in Combination with Nivolumab and and Systemic Chemotherapy for Resectable Hepatic-Limited Metastatic Colorectal Cancer
Study Type: Treatment
Phase: II
NCTID: NCT03547999
Principal Investigator:
Anup Kasi